These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11544938)

  • 1. [Cytokines: current status and prospects in the treatment of skin tumors].
    Nashan D; Luger TA
    Hautarzt; 2001 Aug; 52(8):691-6. PubMed ID: 11544938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of cutaneous malignancies.
    Gibbs P; Gonzalez R; Lee LA; Walsh P
    Clin Dermatol; 2001; 19(3):298-304. PubMed ID: 11479042
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers.
    Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A
    Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma.
    Weber J; Sondak VK; Scotland R; Phillip R; Wang F; Rubio V; Stuge TB; Groshen SG; Gee C; Jeffery GG; Sian S; Lee PP
    Cancer; 2003 Jan; 97(1):186-200. PubMed ID: 12491520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.
    Yurkovetsky ZR; Kirkwood JM; Edington HD; Marrangoni AM; Velikokhatnaya L; Winans MT; Gorelik E; Lokshin AE
    Clin Cancer Res; 2007 Apr; 13(8):2422-8. PubMed ID: 17438101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study.
    Olieman AF; Liénard D; Eggermont AM; Kroon BB; Lejeune FJ; Hoekstra HJ; Koops HS
    Arch Surg; 1999 Mar; 134(3):303-7. PubMed ID: 10088573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous neoplasms].
    Dummer R; Beyeler M; Morcinek J; Burg G
    Praxis (Bern 1994); 2003 Sep; 92(36):1470-8. PubMed ID: 14526630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine therapy in advanced melanoma.
    Kalaaji AN
    J Drugs Dermatol; 2007 Apr; 6(4):374-8. PubMed ID: 17668534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.
    Maurer-Schultze B; Bassukas ID; Hofmockel G
    Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):65-78. PubMed ID: 7773138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.
    Tähtinen S; Kaikkonen S; Merisalo-Soikkeli M; Grönberg-Vähä-Koskela S; Kanerva A; Parviainen S; Vähä-Koskela M; Hemminki A
    PLoS One; 2015; 10(6):e0131242. PubMed ID: 26107883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional agents in the management of cutaneous malignancy: a review.
    Good LM; Miller MD; High WA
    J Am Acad Dermatol; 2011 Feb; 64(2):413-22. PubMed ID: 20334952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of skin and soft tissue tumors].
    Herrmann R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():919-21. PubMed ID: 1983679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What's new in oncodermatology?].
    Bagot M
    Ann Dermatol Venereol; 2009 Dec; 136 Suppl 7():S436-44. PubMed ID: 20110059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model.
    Kalaaji AN; Lu J; Markovic SN; Celis E; Pittelkow MR
    Cytokine; 2010 Mar; 49(3):287-93. PubMed ID: 20060741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited.
    Kim KH; Yavel RM; Gross VL; Brody N
    Dermatol Surg; 2004 Jan; 30(1):116-20. PubMed ID: 14692941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
    Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
    J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Landmark Series: Non-melanoma Skin Cancers.
    Lee AY; Berman RS
    Ann Surg Oncol; 2020 Jan; 27(1):22-27. PubMed ID: 31549317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.